MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
Julie Halkein(University of Liège), Ingrid Struman(University of Liège)
Cited by 492
Related Papers
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
|Basic Research in Cardiology|2013|351
MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells
|PLoS ONE|2011|251
PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin
|Nature Medicine|2014|105
hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells
|Cellular and Molecular Life Sciences|2020|56